In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.

A novel nonmyeloablative conditioning regimen was investigated in 44 patients with hematologic malignancies. The median patient age was 41 years. Many of the patients had high-risk features, including 19 patients with a previous failed transplant. Recipient conditioning consisted of CAMPATH-1H, 20 m...

Full description

Bibliographic Details
Main Authors:	Kottaridis, P, Milligan, D, Chopra, R, Chakraverty, R, Chakrabarti, S, Robinson, S, Peggs, K, Verfuerth, S, Pettengell, R, Marsh, J, Schey, S, Mahendra, P, Morgan, G, Hale, G, Waldmann, H, Elvira, d, Williams, C, Devereux, S, Linch, D, Goldstone, A, Mackinnon, S
Format:	Journal article
Language:	English
Published:	2000

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.

Similar Items